Oscar Health Inc. (OSCR), the New York-based health insurance company with some interesting political connections, is having a moment. And not the good kind.

The company, founded by Joshua Kushner and backed by his brother Jared Kushner (yes, that Jared Kushner—President Donald Trump's son-in-law and former senior advisor), has seen its Momentum score take a nosedive in MarketDash's Edge Stock Rankings. We're talking about a drop from 62.07 to 13.22 in a single week. That's not a slip. That's a tumble.

What's Behind the Momentum Crash?

First, let's talk about what this Momentum score actually measures. It's essentially a gauge of how strong a stock is performing relative to everything else out there, calculated by looking at price movements and volatility across different time frames. Stocks are then ranked as percentiles against each other. When your score drops that dramatically, it means the market isn't feeling your vibe right now.

Oscar Health (OSCR) has been up just 7% year-to-date, which doesn't sound terrible until you realize even that modest gain is now fizzling out. The stock has declined 19.14% over the past month alone, and shares closed down 2.55% on Monday at $14.53.

The broader picture isn't helping either. Health insurance stocks across the board have been under pressure lately, thanks to growing uncertainty around whether subsidies under the Affordable Care Act will be extended. That kind of policy fog tends to make investors nervous, and Oscar's shares have been particularly volatile during this stretch—bouncing around without any clear direction, which tends to confuse momentum-based trading models.

Is There a Silver Lining?

Here's where it gets interesting. Despite the current weakness, some analysts think Oscar could turn things around by 2026. Piper Sandler recently upgraded the stock to "Overweight" with a $25 price target. If they're right, that represents a 72% upside from current levels. Not too shabby.

That said, the stock currently does poorly in MarketDash's Edge Stock Rankings, showing unfavorable price trends across short, medium, and long-term horizons. So while there's optimism about the future, the present isn't looking particularly rosy for Oscar Health. Whether the Kushner connection helps or hurts at this point is anyone's guess, but right now, the market seems to be voting with its feet.